Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
General American Investors Company is an internally managed, closed-end management investment company that has been in operation since 1927. The firm's primary objective is long-term capital appreciation, achieved through investments in a diversified portfolio of common stocks across various industries. Although the company holds significant positions in healthcare, biotechnology, and pharmaceutical stocks, it functions as a financial investment vehicle rather than a research or manufacturing entity. It is publicly traded on the New York Stock Exchange under the symbol GAM and is known for its long history of dividend and capital gain payments. The company is headquartered in New York City and is one of the oldest closed-end funds in the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on General American Investors Company.